A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature.
El-Sahli S, Hua K, Sulaiman A, Chambers J, Li L, Farah E, McGarry S, Liu D, Zheng P, Lee SH, Cui J, Ekker M, Côté M, Alain T, Li X, D'Costa VM, Wang L, Gadde S.
El-Sahli S, et al. Among authors: li x, li l.
Cell Death Dis. 2021 Jan 4;12(1):8. doi: 10.1038/s41419-020-03308-w.
Cell Death Dis. 2021.
PMID: 33414428
Free PMC article.